Form 4 for RMD ResMed|
Accepted 2024-09-13 00:00:00 ET · period of report 2024-09-12 · accession 0001127602-24-023884 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-13 | 2024-09-12 | RMD | Ghoshal Kaushik | Chief Commercial Off, SaaS | M - OptEx | $101.64 | +5,000 | 26.8K | +23% | +$508.2K |
| D | 2024-09-13 | 2024-09-12 | RMD | Ghoshal Kaushik | Chief Commercial Off, SaaS | S - Sale+OE | $252.56 | -5,000 | 21.8K | -19% | -$1.26M |
| D | 2024-09-13 | 2024-09-12 | RMD | Ghoshal Kaushik | Chief Commercial Off, SaaS | M - OptEx | $0.00 | -5,000 | 4,260 | -54% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-09-12 | M | A | 5,000 | $101.64 | 26,788 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2024-09-12 | S | D | 5,000 | $252.56 | 21,788 | D | — | — | |
| 3 | Derivative | ResMed Common Stock Options | 2024-09-12 | M | D | 5,000 | $0.00 | 4,260 | D | $101.64 · 2018-11-14 to 2025-11-14 | 5,000 ResMed Common Stock | (F2) Represents date options first became exercisable. Options vest 1/3 per year. |